Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Virology

• Publication date

  1996-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jvi.70.1.559-565.1996PMID 8523570PMCID PMC189844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

  1995cited by this paper
• Adenovirus type 5 precursor terminal protein-expressing 293 and HeLa cell lines

  1995cited by this paper
• Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2a

  1994cited by this paper
• Pharmacological regulation of AP‐1 transcription factor DNA binding activity 1

  1994cited by this paper
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

  1994cited by this paper
• A late adenovirus factor induces eIF-4E dephosphorylation and inhibition of cell protein synthesis

  1994cited by this paper
• Deletion of the E4 region of the genome produces adenovirus DNA concatemers.

  1994cited by this paper
• DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control.

  1994cited by this paper
• Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53.

  1994cited by this paper
• Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.

  1994cited by this paper
• Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs

  1994cited by this paper
• Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1–deleted adenoviruses

  1993cited by this paper
• Regulated splicing of adenovirus type 5 E4 transcripts and regulated cytoplasmic accumulation of E4 mRNA

  1993cited by this paper
• Two adenovirus proteins with redundant activities in virus growth facilitates tripartite leader mRNA accumulation.

  1993cited by this paper
• Adenovirus early region 4 and viral DNA synthesis.

  1993influential reference
• NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A

  1992cited by this paper
• Widespread long-term gene transfer to mouse skeletal muscles and heart.

  1992cited by this paper
• Construction, characterization, and utilization of cell lines which inducibly express the adenovirus DNA-binding protein.

  1992cited by this paper
• Adenovirus E4orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP-1

  1992influential reference
• Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation.

  1991cited by this paper
• The adenovirus DNA-binding protein stimulates the rate of transcription directed by adenovirus and adeno-associated virus promoters

  1990cited by this paper
• Redundant control of adenovirus late gene expression by early region 4

  1989cited by this paper
• Adenovirus early region 4 is essential for normal stability of late nuclear RNAs

  1989cited by this paper
• Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection

  1989cited by this paper
• c-myc products trans-activate the adenovirus E4 promoter in EC stem cells by using the same target sequence as E1A products

  1988cited by this paper
• Gene product of region E4 of adenovirus type 5 modulates accumulation of certain viral polypeptides

  1988influential reference
• Adenovirus early region 4 is required for efficient virus particle assembly

  1987cited by this paper
• The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs

  1986cited by this paper
• Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression

  1986cited by this paper
• Primary structure and expression of a functional human glucocorticoid receptor cDNA

  1985cited by this paper
• Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff

  1985cited by this paper
• Introduction, stable integration, and controlled expression of a chimeric adenovirus gene whose product is toxic to the recipient human cell

  1984cited by this paper
• mRNAs from human adenovirus 2 early region 4

  1984cited by this paper
• Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity

  1984cited by this paper
• Characterization of the major mRNAs from adenovirus 2 early region 4 by cDNA cloning and sequencing.

  1984cited by this paper
• Splice junctions in adenovirus 2 early region 4 mRNAs: multiple splice sites produce 18 to 24 RNAs

  1984cited by this paper
• The pIC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation.

  1984cited by this paper
• Region-specific initiation of mouse mammary tumor virus RNA synthesis by endogenous RNA polymerase II in preparations of cell nuclei.

  1983cited by this paper
• A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2.

  1983cited by this paper
• Deletion mutants of adenovirus 2: isolation and initial characterization of virus carrying mutations near the right end of the viral genome.

  1981influential reference
• Regulation of early adenovirus transcription: a protein product of early region 2 specifically represses region 4 transcription.

  1980cited by this paper
• Autoregulation of Adenovirus Type 5 Early Gene Expression III. Transcription Studies in Isolated Nuclei

  1979cited by this paper
• An adenovirus type 5 gene function required for initiation of viral DNA replication.

  1975cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper

• Construction and application of adenoviral vectors

  2023cites this paper
• GROWTH HORMONE AND SERUM ALBUMN

  2017cites this paper
• Chapter 1: Introduction

  2016cites this paper
• Adenoviral vector-based strategies against infectious disease and cancer

  2016cites this paper
• Therapeutic applications of endothelial progenitor cells for diabetic ulcer healing

  2016cites this paper
• Entfernung proviraler HIV-1 DNA aus infizierten Zellen mittels nicht-integrierender Vektoren

  2014cites this paper
• Functional studies on factor VIII variants containing different lengths of the B-domain AND The construction of a new helper vector for the production of helper-dependent

  2012cites this paper
• Gene Regulatable Lentiviral Vector System

  2011cites this paper
• Adenovirus-mediated gene transfer.

  2011cites this paper
• Adenoviral Producer Cells

  2010influential citation
• From the first to the third generation adenoviral vector: what parameters are governing the production yield?

  2009cites this paper
• RNA-Interferenz-vermittelte Gentherapie bei Herzinsuffizienz mittels Phospholamban-shRNA exprimierender adenoviraler und AAV–Vektoren

  2009cites this paper
• New insights on adenovirus as vaccine vectors.

  2009cites this paper
• Adenovirus-vectored vaccines

  2008cites this paper
• The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases

  2008cites this paper
• Harnessing the Heat Shock Response to Raise Refined Therapeutic Outcomes

  2008cites this paper
• Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?

  2007cites this paper
• ADENOVIRAL VECTORS FOR PROTEIN EXPRESSION

  2007cites this paper
• Isolation, growth, and purification of defective adenovirus deletion mutants.

  2007cites this paper
• Manipulation of early region 4.

  2007cites this paper
• Adenoviral vector platform for transduction of constitutive and regulated tricistronic or triple‐transcript transgene expression in mammalian cells and microtissues

  2006cites this paper
• Adenovirus Methods and Protocols

  2006cites this paper
• Adenoviral vectors

  2006cites this paper
• The controversial role of adenoviral-derived vectors in gene therapy programs: where do we stand?

  2006cites this paper
• Chimpanzee-origin adenovirus vectors as vaccine carriers

  2006cites this paper
• Functions of the adenovirus E4 proteins and their impact on viral vectors.

  2005cites this paper
• Gene therapy: twenty-first century medicine.

  2005cites this paper
• Modifying xenogeneic immune recognition and engraftment by genetic engineering

  2005cites this paper
• Control of adenovirus packaging

  2005cites this paper
• Induction and Inhibition of Innate Inflammatory Responses by Adenovirus Early Region Proteins

  2005cites this paper
• Preclinical gene therapy studies for hemophilia using adenoviral vectors.

  2004cites this paper
• Robust functional gene validation by adenoviral vectors: one-step Escherichia coli-Derived Recombinant Adenoviral Genome construction

  2004cites this paper
• Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion.

  2004cites this paper
• Recombinant adenoviruses and adenovirus penton vectors: from DNA transfer to direct protein delivery into cell

  2004cites this paper
• Preclinical Gene Therapy Studies for Hemophilia Using Adenoviral Vectors

  2004cites this paper
• Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease

  2004cites this paper
• Adenoviruses as vaccine vectors

  2004cites this paper
• Production of adenovirus vector for gene therapy.

  2003cites this paper
• Gene therapy with viral vectors.

  2003cites this paper
• Adenoviral Vectors for Gene Delivery

  2003cites this paper
• Engineering an improved adenovirus packaging cell line

  2002cites this paper
• Controlled transgene expression by E1‐E4‐defective adenovirus vectors harbouring a “tet‐on” switch system

  2002cites this paper
• Gutted adenoviral vector growth using E1/E2b/E3‐deleted helper viruses

  2002cites this paper
• Humoral Immune Response

  2002cites this paper
• Adenovirus-mediated Gene Transfer of B7.1 Induces Immunological Anti-tumor Effects in a Murine Brain Tumor

  2002cites this paper
• Adenoviral Vector Construction II: Bacterial Systems

  2002cites this paper
• A combined gene delivery by co-transduction of adenoviral and retroviral vectors for cancer gene therapy.

  2002cites this paper
• Diversity and complexity of CD8+ T cell responses against a single epitope of adenovirus E1B.

  2002cites this paper
• Adenovirus vector-directed expression of the neurotrophin-3 receptor (TrkC) in mouse astrocytes

  2001cites this paper
• Adenovirus‐mediated gene transfer in canine eyes: a preclinical study for gene therapy of human uveal melanoma

  2001cites this paper
• Adenovirus vector systems permitting regulated protein expression and their use for in vivo splicing studies

  2001cites this paper
• Transfection and transduction of primary human endothelial cells.

  2001cites this paper
• Gene therapy: promises and problems.

  2001cites this paper
• Adenovirus Vectors with the 100K Gene Deleted and Their Potential for Multiple Gene Therapy Applications

  2001cites this paper
• Degenerated pIX-IVa2 adenoviral vector sequences lowers reacquisition of the E1 genes during virus amplification in 293 cells

  2001cites this paper
• System for Efficient Helper-Dependent Minimal Adenovirus Construction and Rescue

  2001cites this paper
• Gene therapy for hemophilia

  2001cites this paper
• Toxicity Associated with Repeated Administration of First-Generation Adenovirus Vectors Does Not Occur with a Helper-Dependent Vector

  2000cites this paper
• Episomal Segregation of the Adenovirus Enhancer Sequence by Conditional Genome Rearrangement Abrogates Late Viral Gene Expression

  2000cites this paper
• Gene vectors for cytokine expression in vivo.

  2000cites this paper
• Baculovirus vectors repress phenobarbital-mediated gene induction and stimulate cytokine expression in primary cultures of rat hepatocytes

  2000cites this paper
• Adenovirus vectors for human gene therapy.

  2000cites this paper
• Latest Developments in Gene Transfer Technology: Achievements, Perspectives, and Controversies over Therapeutic Applications

  2000cites this paper
• Immune gene therapy of experimental mouse brain tumor with adenovirus-mediated gene transfer of murine interleukin-4

  2000cites this paper
• Adenovirus Vector Pseudotyping in Fiber-Expressing Cell Lines: Improved Transduction of Epstein-Barr Virus-Transformed B Cells

  2000cites this paper
• Modulation of the Inflammatory Properties and Hepatotoxicity of Recombinant Adenovirus Vectors by the Viral E4 Gene Products

  2000cites this paper
• Stable transduction of actively dividing cells via a novel adenoviral/episomal vector.

  2000cites this paper
• Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses

  2000cites this paper
• An improved anion-exchange HPLC method for the detection and purification of adenoviral particles

  2000cites this paper
• Production of first generation adenovirus vectors: a review

  2000cites this paper
• Gene-transfer systems for human endothelial cells. stewart.martin@nottingham.ac.uk.

  2000cites this paper
• RESEARCH ARTICLE Baculovirus vectors repress phenobarbital-mediated gene induction and stimulate cytokine expression in primary cultures of rat hepatocytes

  2000cites this paper
• Gene-transfer systems for human endothelial cells

  2000cites this paper
• Canine Adenovirus Vectors: an Alternative for Adenovirus-Mediated Gene Transfer

  2000cites this paper
• RGD Inclusion in the Hexon Monomer Provides Adenovirus Type 5-Based Vectors with a Fiber Knob-Independent Pathway for Infection

  1999cites this paper
• Tools of gene transfer in organ transplantation.

  1999cites this paper
• The molecular weight ratio of monomethoxypolyethylene glycol (mPEG) to protein determines the immunotolerogenicity of mPEG proteins.

  1999cites this paper
• Gene Therapy of Familial Hypercholesterolemia

  1999cites this paper
• Arterial Gene Transfer

  1999cites this paper
• An Adenovirus–Epstein-Barr Virus Hybrid Vector That Stably Transforms Cultured Cells with High Efficiency

  1999influential citation
• Regulation of Adenovirus-Mediated Transgene Expression by the Viral E4 Gene Products: Requirement for E4 ORF3

  1999cites this paper
• Induction of Apoptosis of Cytokine-Producing Bladder Cancer Cells by Adenovirus-Mediated I kappa B alpha Overexpression

  1999cites this paper
• Gene Transfer Technology in Therapy: Current Applications and Future Goals

  1999cites this paper
• Cardiovascular Specific Gene Expression

  1999cites this paper
• Gene therapy for lung disease.

  1999cites this paper
• Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement

  1999cites this paper
• Generation of recombinant adenovirus vector with infectious adenoviral genome released from cosmid-based vector by simple procedure allowing complex manipulation.

  1998cites this paper
• HVJ (Sendai virus) liposome-mediated gene transfer: current status and future perspectives (review).

  1998cites this paper
• Gene transfer to schwann cells after peripheral nerve injury: A delivery system for therapeutic agents

  1998cites this paper
• Recent advances, prospects and problems in designing new strategies for oligonucleotide and gene delivery in therapy.

  1998cites this paper
• Haemophilia A gene therapy

  1998cites this paper
• Hemophilia A: current treatment and future gene therapy

  1998cites this paper
• Site-Specific Integration in Mammalian Cells Mediated by a New Hybrid Baculovirus–Adeno-Associated Virus Vector

  1998cites this paper
• In Vitro and In Vivo Biology of Recombinant Adenovirus Vectors with E1, E1/E2A, or E1/E4 Deleted

  1998cites this paper
• Strategies of gene transfer to the kidney.

  1998cites this paper
• High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels of α 1-Antitrypsin with Negligible Toxicity

  1998cites this paper
• Gene therapy for restenosis: getting nearer the heart of the matter.

  1998cites this paper
• New Helper Cells and Matched Early Region 1-Deleted Adenovirus Vectors Prevent Generation of Replication-Competent Adenoviruses

  1998cites this paper
• Gene transfer technology in therapy: current applications and future goals.

  1998cites this paper
• Viral vectors for gene therapy.

  1998cites this paper